Insufficient scRNA-seq data for expression of ZNF304 at single-cell level.
Insufficient scRNA-seq data for expression of ZNF304 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 816.43 | 245 / 245 | 100% | 12.05 | 500 / 502 |
breast | 100% | 871.85 | 459 / 459 | 99% | 16.80 | 1112 / 1118 |
ovary | 100% | 819.28 | 180 / 180 | 99% | 10.16 | 427 / 430 |
thymus | 100% | 1123.38 | 653 / 653 | 99% | 11.84 | 600 / 605 |
brain | 99% | 839.81 | 2621 / 2642 | 100% | 11.90 | 704 / 705 |
esophagus | 100% | 907.14 | 1445 / 1445 | 99% | 9.18 | 181 / 183 |
adrenal gland | 100% | 1167.77 | 258 / 258 | 99% | 9.87 | 227 / 230 |
lung | 100% | 879.79 | 577 / 578 | 97% | 8.90 | 1124 / 1155 |
skin | 100% | 970.98 | 1809 / 1809 | 97% | 9.99 | 457 / 472 |
kidney | 100% | 638.56 | 89 / 89 | 96% | 9.48 | 869 / 901 |
pancreas | 94% | 286.48 | 308 / 328 | 97% | 7.36 | 173 / 178 |
bladder | 100% | 797.62 | 21 / 21 | 83% | 6.77 | 420 / 504 |
uterus | 100% | 802.75 | 170 / 170 | 76% | 6.74 | 349 / 459 |
liver | 97% | 296.50 | 219 / 226 | 71% | 3.59 | 287 / 406 |
stomach | 99% | 575.15 | 355 / 359 | 69% | 4.54 | 196 / 286 |
intestine | 100% | 839.57 | 966 / 966 | 50% | 2.92 | 261 / 527 |
adipose | 100% | 874.86 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 6.85 | 29 / 29 |
spleen | 100% | 1155.69 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.69 | 1 / 1 |
blood vessel | 100% | 679.45 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 530.56 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 750.85 | 855 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 6.86 | 76 / 80 |
tonsil | 0% | 0 | 0 / 0 | 87% | 7.06 | 39 / 45 |
peripheral blood | 48% | 327.11 | 446 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006325 | Biological process | chromatin organization |
GO_0090309 | Biological process | positive regulation of DNA methylation-dependent heterochromatin formation |
GO_0001525 | Biological process | angiogenesis |
GO_0050679 | Biological process | positive regulation of epithelial cell proliferation |
GO_0007229 | Biological process | integrin-mediated signaling pathway |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_2000811 | Biological process | negative regulation of anoikis |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_1990841 | Molecular function | promoter-specific chromatin binding |
GO_0005515 | Molecular function | protein binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0046872 | Molecular function | metal ion binding |
Gene name | ZNF304 |
Protein name | ZNF304 protein Zinc finger protein 304 (KRAB-containing zinc finger protein) Zinc finger protein 304 |
Synonyms | |
Description | FUNCTION: Acts as a transcriptional regulator and plays a role in gene silencing . Probably forms a corepressor complex required for activated KRAS-mediated promoter hypermethylation and transcriptional silencing of several tumor suppressor genes (TSGs) or other tumor-related genes in colorectal cancer (CRC) cells . Also required to maintain a transcriptionally repressive state of genes in undifferentiated embryonic stem cells (ESCs) by inducing trimethylation of 'Lys-27' of histone H3 (H3K27me3) in a Polycomb group (PcG) complexes-dependent manner. Associates at promoter regions of TSGs and mediates the recruitment of the corepressor complex containing the scaffolding protein TRIM28, methyltransferase DNMT1 and histone methyltransferase SETDB1 and/or the PcG complexes at those sites . Transcription factor involved in the metastatic cascade process by inducing cell migration and proliferation and gain resistance to anoikis of ovarian carcinoma (OC) cells via integrin-mediated signaling pathways . Associates with the ITGB1 promoter and positively regulates beta-1 integrin transcription expression . Promotes angiogenesis . Promotes tumor growth . . |
Accessions | ENST00000282286.6 Q2T9G7 ENST00000391705.7 ENST00000598744.1 E7EQD3 M0QZ59 ENST00000443917.6 Q2T9G8 Q9HCX3 |